Cogent Biosciences Inc.
8.07
0.70 (9.50%)
At close: Jan 15, 2025, 1:41 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
PE Ratio -2.43 -5.12 -4.63 -1.87 -0.72 -3.17 -3.02 -3.36 -9.24
PS Ratio n/a n/a n/a 15.81 0.98 11.25 9.20 9.58 20.39
PB Ratio 1.82 2.66 1.55 0.53 0.69 1.82 2.72 1.16 0.88
P/FCF Ratio -2.99 -5.41 -5.49 -3.47 -0.53 -3.32 -2.88 -2.77 3.87
P/OCF Ratio -3.05 -5.72 -5.66 -3.47 -0.53 -3.37 -2.98 -3.27 3.44
OCF/S Ratio n/a n/a n/a -4.55 -1.85 -3.34 -3.09 -2.93 5.93
Debt / Equity Ratio 0.07 0.08 0.01 0.02 0.19 n/a n/a n/a n/a
Quick Ratio 7.09 9.87 13.04 18.70 3.06 3.25 3.78 7.98 12.49
Current Ratio 7.09 9.87 13.04 18.70 3.06 3.25 3.79 7.98 12.49
Asset Turnover n/a n/a n/a 0.03 0.46 0.11 0.17 0.08 0.03
Interest Coverage n/a -37.06 n/a n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.75 -0.52 -0.34 -0.28 -0.95 -0.57 -0.9 -0.35 -0.09
Return on Assets (ROA) -0.61 -0.44 -0.31 -0.26 -0.61 -0.4 -0.52 -0.24 -0.07
Return on Capital (ROIC) -0.76 -0.54 -0.35 -0.35 -0.89 -0.59 -0.69 -0.29 -0.08
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a 99.67% 99.81% 100.00% 100.00% 100.00% 100.00%
Net Profit Margin n/a n/a n/a -844.25% -134.55% -354.76% -304.93% -285.19% -220.76%
Pretax Profit Margin n/a n/a n/a -950.43% -141.49% -354.76% -304.93% -285.19% -220.76%
Operating Profit Margin n/a n/a n/a -1.04K% -143.02% -369.89% -312.82% -300.08% -220.76%
FCF Margin n/a n/a n/a -455.47% -184.66% -339.41% -319.94% -345.35% 526.52%
EBITDA Margin n/a n/a n/a -439.19% -137.27% -356.32% -298.82% -287.02% -214.77%